Correction: METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation
Chengjie Lin, Ting Li, Yan Wang, Shihui Lai, Yue Huang, Zhenyun Guo, Xiang Zhang, Shangeng Weng
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsRNA modifications and cancer · Cancer-related gene regulation · Cancer-related molecular mechanisms research
Correction to: Cell Death and Disease 10.1038/s41419-023-05715-1, published online 28 March 2023
During the final figure assembly and layout process using Adobe Illustrator, an unfortunate technical error occurred. Specifically, the same data image was inadvertently duplicated and assigned to two different experimental groups in Fig. 7H. This was purely an error in the figure assembly and labeling process and does not reflect an error in the underlying experimental data or data analysis. The image currently representing group-sh-METTL3 & DDX23 in Fig. 7H is incorrect identical to the image representing group-sh-NC in Fig. 7H.
Original Figure 7
Amended Figure 7
The original article has been updated.